secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001104659-22-116082
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals Raises $20M via Private Placement of Convertible Preferred Stock
--------------------------------------------------------------------------------

- Offering includes 1,900,000 Series F and 100,000 Series G shares at $9.50 each.
- Each preferred share convertible into common at $1.00 per share (5% original issue discount).
- Investors agreed to vote Series F in favor of reverse stock split; Series G votes mirror proportions.
- Company filed certificates of designation and entered registration rights agreement for resale.
- A.G.P./Alliance Global Partners acted as placement agent with $1M cash fee plus expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922116082/0001104659-22-116082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000110465922116082/tm2230043d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-116082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer